Table 1.
Pre-treatment/At the beginning of experimental period | ||||
---|---|---|---|---|
Groups | CTRL | DOX | THIA | DOX+THIA |
Parameters | ||||
Ivsd (cm) | 0.136±0.02 | 0.153±0.01 | 0.133±0.02 | 0.136±0.01 |
LviDd(cm) | 0.390±0.01 | 0.475±0.01 | 0.390±0.02 | 0.423±0.05 |
LVPWd(cm) | 0.157±0.02 | 0.162±0.02 | 0.151±0.02 | 0.157±0.01 |
IVSs(cm) | 0.123±0.01 | 0.165±0.02 | 0.123±0.04 | 0.122±0.02 |
LVIDs(cm) | 0.225±0.03 | 0.233±0.02 | 0.233±0.01 | 0.225±0.02 |
LVPWs(cm) | 0.148±0.01 | 0.178±0.01 | 0.148±0.01 | 0.147±0.01 |
FS(%) | 49.5±3.21 | 50.9±6.34 | 49.0±2.91 | 51.0±4.05 |
LVEDV | 0.149±0.01 | 0.61±0.01 | 0.149±0.04 | 0.188±0.03 |
LVESV | 0.030±0.01 | 0.034±0.03 | 0.034±0.01 | 0.030±0.03 |
EF(%) | 79.59±2.76 | 87.11±5.33 | 77.40±3.22 | 83.82±9.71 |
Post-treatment/At the end of experimental period | ||||
Groups | CTRL | DOX | THIA | DOX+THIA |
Ivsd (cm) | 0.199±0.02 | 0.174±0.02 | 0.174±0.02 | 0.191±0.02 |
LviDd(cm) | 0.403±0.20 | 0.466±0.03 | 0.564±0.06 | 0.318±0.03 |
LVPWd(cm) | 0.292±0.02 | 0.246±0.02 | 0.237±0.02 | 0.254±0.01 |
IVSs(cm) | 0.191±0.03 | 0.186±0.02 | 0.199±0.01 | 0.169±0.01 |
LVIDs(cm) | 0.182±0.01 | 0.288±0.05 | 0.275±0.01 | 0.159±0.01 |
LVPWs(cm) | 0.258±0.02 | 0.258±0.02 | 0.220±0.01 | 0.135±0.01 |
FS(%) | 54.7±5.76 | 38.2±6.29 | 51.1±3.32 | 46.7±2.26 |
p =0.061 | p =0.003 | p =0.238 | p =0.008 | |
LVEDV | 0.163±0.02 | 0.247±0.04 | 0.424±0.03 | 0.083±0.01 |
LVESV | 0.016±0.02 | 0.062±0.04 | 0.054±0.04 | 0.011±0.01 |
EF(%) | 90.00±8.34 | 74.83±9.88 | 87.16±8.02 | 86.72±4.87 |
Results are presented as mean±SEM. Statistical significance was determined by Repeat Measured ANOVA (RM-ANOVA). Statistical threshold of 0.05.